KANABO GROUP PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.7 GBX | 0.00% |
|
-2.86% | -39.29% |
| Mar. 28 | Kanabo shares soar after company announces UK mental health service | AN |
| Mar. 28 | Kanabo Group plc Announces Expansion of Treat It Clinic to Offer Mental Health Treatments | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Kanabo Group plc is a United Kingdom-based patient-focused provider of digital health services and specialist medicines, including medicinal cannabis. The Companyâs principal activities are the distribution and development of cannabis derived medical and wellness products. The Company is focused on the distribution of cannabis-derived products for medical patients, and non- tetrahydrocannabinol (THC) products for cannabidiol (CBD) consumers. It has conducted research and development (R&D) in order to develop cannabis extract formulas, medical-grade vaporizers and various non-smoking consumption solutions. Its clinical and validation activities, including safety and efficiency tests, are conducted in Israel. The Company operates through two segments: Primary case and Secondary case. Primary case segment is involved in the telepharma services provided by GPS. Secondary case segment is involved in the distribution and development of cannabis-derived medical and wellness products.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q4 2023 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -39.29% | 13.37M | |
| +25.61% | 672B | |
| +25.87% | 570B | |
| -5.24% | 360B | |
| +16.49% | 321B | |
| +8.28% | 300B | |
| +7.09% | 217B | |
| -9.12% | 204B | |
| +5.01% | 199B | |
| -8.75% | 149B |
- Stock Market
- Equities
- KNB Stock
- News Kanabo Group Plc
- Kanabo Backs Out Of Materia Acquisition To Pursue Strategic Partnership
